The amniotic membrane is rapidly becoming a cornerstone in modern dry eye treatment and corneal surface disease management. Once seen as highly specialized, this therapy is now accessible for optometrists across Canada thanks to initiatives from Ophthalmologic Canada. In a recent episode of The 2020 Podcast, host Dr. Harbir Sian sat down with Dr. Julian Prosia to explore how the therapy works, why it matters, and how clinicians can incorporate it into daily practice.
Published on 23 hours ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate